Dr. Shahzad Haider

Dr. Putcha is a pulmonary and critical care physician. She is an expert in the diagnosis and treatment of lung disease (specifically obstructive lung diseases such as COPD and asthma), and in the care of critically ill patients in the Medical ICU. She is a member of the Lung Research Conference Planning Committee and provides teaching to medical students and residents at Johns Hopkins. Dr. Putcha is rated as a Distinguished provider by MediFind in the treatment of Emphysema. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Cerebral Hypoxia, and Asthma.

Abbas Omais is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in White Plains, Maryland. Dr. Omais is rated as a Distinguished provider by MediFind in the treatment of Emphysema. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Asthma in Children, Asthma, and Gastrostomy. Dr. Omais is currently accepting new patients.

Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is rated as a Distinguished provider by MediFind in the treatment of Emphysema. His top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, and Hepatitis B.